1. Home
  2. OGN vs TROX Comparison

OGN vs TROX Comparison

Compare OGN & TROX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.38

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Tronox Holdings plc (UK)

TROX

Tronox Holdings plc (UK)

HOLD

Current Price

$7.98

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGN
TROX
Founded
1923
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2020
2012

Fundamental Metrics

Financial Performance
Metric
OGN
TROX
Price
$13.38
$7.98
Analyst Decision
Hold
Hold
Analyst Count
5
8
Target Price
$11.40
$6.36
AVG Volume (30 Days)
5.0M
3.0M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
0.60%
2.07%
EPS Growth
N/A
N/A
EPS
0.55
N/A
Revenue
$6,216,000,000.00
$2,898,000,000.00
Revenue This Year
$0.45
$6.94
Revenue Next Year
$1.67
$5.91
P/E Ratio
$24.28
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.69
$2.86
52 Week High
$13.48
$10.59

Technical Indicators

Market Signals
Indicator
OGN
TROX
Relative Strength Index (RSI) 74.68 42.80
Support Level $10.05 $6.13
Resistance Level $13.46 $8.80
Average True Range (ATR) 0.05 0.46
MACD -0.22 -0.06
Stochastic Oscillator 47.50 24.04

Price Performance

Historical Comparison
OGN
TROX

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About TROX Tronox Holdings plc (UK)

Tronox Holdings PLC is a vertically integrated manufacturer of TiO2 pigment. It operates titanium-bearing mineral sand mines and beneficiation and smelting operations in Australia & South Africa to produce feedstock materials that can be processed into TiO2 for pigment, high-purity titanium chemicals, including titanium tetrachloride, and ultrafine TiO2 used in certain specialty applications. TiO2 and titanium feedstock, are used to produce paints and coatings, as well as plastics, paper, and printing ink. It has three pigment production facilities in the United States, the Netherlands, and Western Australia and three mining operations in Western Australia and South Africa. Europe, the Middle East, and Africa regions contribute the majority of revenue.

Share on Social Networks: